What is the initial management of acute cholangitis and cholecystitis according to the Tokyo guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Management of Acute Cholangitis and Cholecystitis

For acute cholangitis, immediately administer broad-spectrum antibiotics within 1 hour if septic shock is present (or within 4 hours if stable), assess severity using the three-tier Tokyo Guidelines grading system, and perform urgent biliary drainage for Grade III (severe) disease or early drainage for Grade II (moderate) disease if initial medical treatment fails within 12-24 hours. 1, 2, 3

Immediate Assessment and Stabilization

Vital Signs and Urgency Determination

  • Measure vital signs immediately upon presentation to determine if the situation is urgent, and begin initial medical treatment including respiratory/circulatory management without waiting for definitive diagnosis if the case appears critical 3
  • Look specifically for signs of organ dysfunction: cardiovascular instability (hypotension requiring vasopressors), respiratory dysfunction (requiring ventilatory support), neurological dysfunction, renal dysfunction, hepatic dysfunction, or hematological dysfunction 1, 4

Antibiotic Administration Timing

  • Administer antibiotics within 1 hour in cases of septic shock 1, 2
  • Administer antibiotics within 4 hours after diagnostic studies in cases without shock 1, 2
  • Use broad-spectrum empiric coverage including piperacillin/tazobactam, carbapenems (imipenem/cilastatin, meropenem, ertapenem), or 4th-generation cephalosporins targeting Gram-negative enteric bacteria 5, 1, 2

Diagnostic Workup

Clinical Diagnosis

  • Diagnose acute cholangitis when Charcot's triad is present: fever/chills, right upper quadrant or epigastric abdominal pain, and jaundice 4
  • When the complete triad is absent, confirm diagnosis with laboratory data showing inflammation (elevated WBC or CRP) plus imaging demonstrating biliary obstruction or dilatation 1, 4

Imaging Strategy

  • Perform trans-abdominal ultrasound as first-line imaging for initial evaluation, which detects cholelithiasis in approximately 98% of cases 1
  • Use advanced imaging (MRCP or EUS) for common bile duct stone detection when ultrasound is inconclusive 1, 2
  • Reserve CT imaging for unstable patients, high suspicion of malignancy, or suspected hepatic abscesses 1

Acute Cholecystitis Diagnosis

  • Require local signs of inflammation (Murphy's sign) and systemic signs (fever) for definite diagnosis 1
  • Ultrasound showing stones plus ultrasonographic Murphy's sign has a 92% positive predictive value 1

Severity Assessment Using Tokyo Guidelines Classification

Grade III (Severe) - Presence of Organ Dysfunction

  • At least one new-onset organ dysfunction defines severe cholangitis: cardiovascular, respiratory, neurological, renal, hepatic, or hematological 1, 4
  • Requires urgent biliary drainage within hours after hemodynamic stabilization 1, 6, 3
  • Provide appropriate organ support and intensive care management 6, 3

Grade II (Moderate) - Non-Responsive to Initial Treatment

  • Defined by any two prognostic factors: abnormal WBC count, high fever (≥39°C), age ≥75 years, hyperbilirubinemia (total bilirubin ≥5 mg/dL), or hypoalbuminemia (<0.7× lower limit of normal) 1
  • Perform early biliary drainage if no response to initial medical treatment within 12-24 hours 1, 6, 3
  • Endoscopic drainage is preferred over surgical approach 1

Grade I (Mild) - Responsive to Initial Treatment

  • Clinical findings and laboratory data improve with initial medical treatment 4
  • Initial medical treatment including antibiotics is sufficient for most cases 6, 3
  • Consider biliary drainage only if patient does not respond to initial treatment 6, 3

Biliary Drainage Strategy

Drainage Timing by Severity

  • Grade III (Severe): Urgent drainage within hours after hemodynamic stabilization 1, 3
  • Grade II (Moderate): Early drainage, especially if no improvement within 12-24 hours of medical treatment 1, 6
  • Grade I (Mild): Drainage only if non-responsive to medical management 6, 3

Drainage Method Selection

  • Endoscopic drainage is the preferred first-line approach for all severity grades 1
  • Percutaneous transhepatic drainage or EUS-guided drainage are alternative methods when endoscopic approach is not feasible 2, 3
  • Avoid surgical drainage in severe cholangitis due to high morbidity and mortality 2

Combined Procedures

  • For Grade I cholangitis with choledocholithiasis, endoscopic sphincterotomy and stone extraction may be performed simultaneously with biliary drainage if the patient's condition permits 6, 3
  • For Grade II and III, treat the underlying etiology only after the patient's general condition has improved 6, 3

Antibiotic Duration and Adjustment

Duration Based on Drainage Success

  • Limit antibiotic therapy to 3 days post-drainage in cases with successful biliary drainage 1, 2
  • Continue antibiotics until anatomical resolution in cases with incomplete drainage or residual stones 1
  • Treatment should last no more than 24 hours for prophylaxis in uncomplicated cases 5

Antibiotic Adjustment

  • Adjust therapy according to bile and blood culture results when available 5, 2
  • In cases of biliary fistula, biloma, or bile peritonitis, use piperacillin/tazobactam, imipenem/cilastatin, meropenem, ertapenem, or aztreonam associated with amikacin in cases of shock 5
  • Add fluconazole in fragile patients and cases of delayed diagnosis 5

Management of Acute Cholecystitis

Grade I (Mild) Cholecystitis

  • Early laparoscopic cholecystectomy is the first-line treatment 6
  • Perform surgery during the same admission when feasible 6

Grade II (Moderate) Cholecystitis

  • Initial medical treatment with antimicrobial agents followed by delayed/elective laparoscopic cholecystectomy is the first-line approach 6
  • Consider gallbladder drainage in non-responders to initial medical treatment 6

Grade III (Severe) Cholecystitis

  • Provide appropriate organ support in addition to initial medical treatment 6
  • Perform urgent or early gallbladder drainage 6
  • Elective cholecystectomy can be performed after improvement of the acute inflammatory process 6

Critical Pitfalls to Avoid

  • Do not delay antibiotic administration beyond 1 hour in septic shock or 4 hours in stable patients 1, 2
  • Do not attempt surgical drainage as first-line therapy in severe cholangitis due to excessive mortality risk 2
  • Do not continue antibiotics beyond 3 days if successful biliary drainage has been achieved, as this promotes resistance without added benefit 1, 2
  • Do not perform definitive treatment of underlying etiology (such as stone extraction) in Grade II or III cholangitis until the patient's condition has stabilized 6, 3

References

Guideline

Diagnostic and Treatment Guidelines for Acute Cholangitis and Cholecystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Role of TG13 Classification in Managing Acute Cholangitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines.

Journal of hepato-biliary-pancreatic surgery, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

TG13 flowchart for the management of acute cholangitis and cholecystitis.

Journal of hepato-biliary-pancreatic sciences, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.